Publication & Citation Trends
Publications
0 total
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects OA
Cited by 9
Semantic Scholar
Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
Cited by 1
Semantic Scholar
Abstract 3093: Molecular profiling of tisotumab vedotin-treated patients identified immune pathways associated with clinical activity, supporting the multimodal mechanism of action
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(106)
Cancer Genomics and Diagnostics
(89)
Lung Cancer Treatments and Mutations
(34)
Monoclonal and Polyclonal Antibodies Research
(33)
T-cell and B-cell Immunology
(23)
Affiliations
Boston Children's Hospital
Apple (Israel)
Johns Hopkins University
George Mason University
University of Pittsburgh